North America
RemeGen Presents Promising Phase II Trial Results for Disitamab Vedotin and Toripalimab in Muscle-Invasive Bladder Cancer at ASCO GU 2025
RemeGen Co., Ltd. (RemeGen) has announced new efficacy and safety data from the Phase II clinical trial (NCT05297552, Study ID: RC48-C017) evaluating Disit...
February 17, 2025 | News
Australia’s Navi Medical Technologies secures FDA clearance for Neonav ECG Tip Location System expanding pediatric vascular access in the US Victoria and globally
Navi Medical Technologies has announced that its Neonav® ECG Tip Location System has received 510(k) clearance from the U.S. Food and Drug Administrati...
February 17, 2025 | News
Innovent’s IBI363 Secures Second FDA Fast Track Designation for Advanced Lung Cancer
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...
February 17, 2025 | News
Stryker Unveils ProCeed Hospital Bed to Enhance Patient Care and Ease Caregiver Burden
Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of the ProCeed hospital bed, offering simplicity while enhancing care acr...
February 17, 2025 | News
Accropeutics Doses First Patient in Phase Ib Trial of AC-101 for Moderate-to-Severe Ulcerative Colitis
Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms ...
February 14, 2025 | News
OnCusp Therapeutics Secures FDA Fast Track Designation for CUSP06 in Platinum-Resistant Ovarian Cancer
OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validat...
February 13, 2025 | News
Thermo Fisher Scientific Introduces Invitrogen™ EVOS™ S1000 for Advanced Spatial Tissue Imaging
Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging System. This advance...
February 13, 2025 | News
PHC Corporation Partners with CCRM to Advance T-Cell Expansion for Cell and Gene Therapies
PHC Corporation has signed a Master Collaboration Agreement with CCRM, a global leader in regenerative medicine and biomanufacturing, to jointly develop pr...
February 12, 2025 | News
Taiwan's Caliway Biopharmaceuticals Reports Groundbreaking Results for CBL-514 in U.S. and Canada Phase 2b Study
Caliway Biopharmaceuticals unveiled the impressive results of its second Phase 2b clinical study (CBL-0205) for CBL-514, the world’s first in...
February 11, 2025 | News
Fresenius Kabi Launches Calcitonin Salmon Injection to Treat Bone Disorders and Hypercalcemia
Fresenius Kabi, an operating company of Fresenius, announced it has introduced Calcitonin Salmon Injection, USP Synthetic, a calcium regulator, for the tre...
February 11, 2025 | News
Pfizer and Astellas Announce Sustained Survival Benefit in Advanced Urothelial Cancer with PADCEV® and KEYTRUDA® Combination
Enfortumab vedotin plus pembrolizumab continues to demonstrate superior efficacy versus chemotherapy in a broad population, reinforcing the combination a...
February 11, 2025 | News
AbbVie Announces FDA Approval of EMBLAVEO™, a Groundbreaking Antibiotic for Complicated Intra-Abdominal Infections
AbbVie announced the U.S. Food and Drug Administration (FDA) approval of EMBLAVEO™ (aztreonam and avibactam), marking a pivotal step in the fight aga...
February 10, 2025 | News
Thermo Fisher Secures FDA Clearance for Multiplex Test Targeting Four Major Respiratory Viruses
Thermo Fisher Scientific has announced the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Applied Biosystems™ TaqPath&trad...
February 10, 2025 | News
Henlius and Dr. Reddy’s Forge Licensing Deal for Daratumumab Biosimilar in U.S. and Europe
Shanghai Henlius Biotech, Inc. announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Redd...
February 07, 2025 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
